Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Azalea Vision announced the successful demonstration of the ALMA Lens, marking the debut of the first functional prototype for the Azalea smart contact lens platform. The ALMA proprietary device is designed to provide a non-surgical solution for individuals dealing with…

What Is Irvine–Gass Syndrome? Irvine–Gass Syndrome, also known as cystoid macular edema (CME), is a notable complication that can occur after cataract surgery. It is characterized by the accumulation of fluid in the macula, the central region of the retina…

Roth spots are retinal hemorrhages with white or pale centers. They are named after Moritz Roth, who first described them in the late 19th century. In medical terms, Roth spots represent a significant clinical finding as they may indicate an…

Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…

In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…

Meridian Medical, headquartered in Switzerland, announced the launch of its line of ophthalmic lasers in the United States, following a series of FDA approvals. The FDA approval, received on January 25, includes the MR Q family of lasers, which offer…

The European Society of Cataract and Refractive Surgeons (ESCRS) Winter Meeting in Frankfurt at Congress Centre Messe Frankfurt, scheduled for February 15-18, 2024, promises an array of new sessions and activities aimed at fostering collaboration, learning, and networking within the…

Eyenovia Inc. announced that the FDA has approved Mydcombi, a groundbreaking ophthalmic spray that induces mydriasis for diagnostic procedures and short-term pupil dilation. This marks the first approved, fixed-dose combination of tropicamide and phenylephrine in the United States and also…

In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…

Oertli Instrumente announced that the OS 4 surgical platform is now available with four new features for greater comfort in retinal, glaucoma and cataract surgery. Oertli’s OS 4 platform is a powerful, multifaceted system designed for retinal, glaucoma, and cataract…